Ratings by Piper Sandler (Yasmeen Rahimi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 6/12/2026 | Tenax Therapeutics | TENX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2026 | Oruka Therapeutics | ORKA | Maintain | Overweight (N/A) |
|
Details | ||
| 6/1/2026 | Tenax Therapeutics | TENX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/21/2026 | Roivant Sciences | ROIV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Bright Minds Biosciences Inc. | DRUG | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2026 | Climb Bio | CLYM | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2026 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2026 | Avalo Therapeutics Inc. | AVTX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2026 | Nektar Therapeutics | NKTR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2026 | AnaptysBio | ANAB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2026 | First Tracks Biotherapeutics | TRAX | New Coverage | Overweight (N/A) |
23.27 (16.69) |
-28.28% | Details | |
| 4/29/2026 | Design Therapeutics Inc | DSGN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/13/2026 | Palisade Bio Inc. | PALI | Maintain | Overweight (N/A) |
|
Details | ||
| 4/7/2026 | Inventiva SA | IVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/7/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Neutral (Overweight) |
52.25 (53.01) |
1.45% | Details | |
| 4/1/2026 | Tvardi Therapeutics Inc | TVRD | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2026 | AnaptysBio | ANAB | Maintain | Overweight (N/A) |
|
Details | ||
| 3/24/2026 | Oruka Therapeutics | ORKA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/12/2026 | Pliant Therapeutics | PLRX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2026 | Design Therapeutics Inc | DSGN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/4/2026 | ArthroCare | ARTC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2026 | Climb Bio | CLYM | New Coverage | Overweight (N/A) |
5.56 (12.75) |
129.32% | Details | |
| 2/9/2026 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2026 | Korro Bio Inc. | KRRO | Upgrade | Overweight (Neutral) |
10.74 (13.77) |
28.21% | Details | |
| 1/28/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/28/2026 | Shattuck Labs | STTK | New Coverage | Overweight (N/A) |
4.06 (6.01) |
48.03% | Details | |
| 1/27/2026 | BioAge Labs Inc | BIOA | New Coverage | Overweight (N/A) |
18.81 (22.83) |
21.37% | Details | |
| 1/26/2026 | Nektar Therapeutics | NKTR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/23/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/20/2026 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Overweight) |
35.10 (58.02) |
65.3% | Details | |
| 1/9/2026 | Rapt Therapeutics | RAPT | New Coverage | Overweight (N/A) |
32.42 (35.10) |
8.27% | Details | |
| 1/8/2026 | Ventyx Biosciences Inc | VTYX | Downgrade | Neutral (Overweight) |
13.73 (14.00) |
1.97% | Details | |
| 12/29/2025 | Palisade Bio Inc. | PALI | New Coverage | Overweight (N/A) |
2.20 (1.92) |
-12.73% | Details | |
| 12/19/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/18/2025 | Oruka Therapeutics | ORKA | New Coverage | Overweight (N/A) |
28.94 (82.09) |
183.66% | Details | |
| 12/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/13/2025 | Korro Bio Inc. | KRRO | Downgrade | Neutral (Overweight) |
31.42 (10.74) |
-65.82% | Details | |
| 10/28/2025 | Structure Therapeutics | GPCR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2025 | Prothena Corp | PRTA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/20/2025 | Upstream Bio | UPB | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2025 | AnaptysBio | ANAB | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2025 | Tvardi Therapeutics Inc | TVRD | Downgrade | Neutral (Overweight) |
41.60 (2.35) |
-94.35% | Details | |
| 10/10/2025 | Inventiva SA | IVA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/6/2025 | LB Pharmaceuticals Inc | LBRX | New Coverage | Overweight (N/A) |
15.46 (30.48) |
97.15% | Details | |
| 10/3/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/2/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/29/2025 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/15/2025 | Nektar Therapeutics | NKTR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | Tourmaline Bio | TRML | Downgrade | Neutral (Overweight) |
47.60 (47.98) |
0.8% | Details | |
| 9/8/2025 | Tenax Therapeutics | TENX | New Coverage | Overweight (N/A) |
6.00 (12.93) |
115.5% | Details | |
| 8/28/2025 | Prothena Corp | PRTA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/27/2025 | Inventiva SA | IVA | New Coverage | Overweight (N/A) |
4.66 (3.46) |
-25.75% | Details | |
| 8/26/2025 | Upstream Bio | UPB | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2025 | Pliant Therapeutics | PLRX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/21/2025 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/10/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/10/2025 | Verona Pharma | VRNA | Downgrade | Neutral (Overweight) |
104.77 (106.91) |
2.04% | Details | |
| 7/7/2025 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/23/2025 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 6/17/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/12/2025 | Tvardi Therapeutics Inc | TVRD | New Coverage | Overweight (N/A) |
26.05 (41.60) |
59.69% | Details | |
| 6/11/2025 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/9/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/5/2025 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/27/2025 | Prothena Corp | PRTA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2025 | Altimmune | ALT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 4/1/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2025 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2025 | Lexicon Pharmaceuticals | LXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2025 | Avalo Therapeutics Inc. | AVTX | New Coverage | Overweight (N/A) |
6.60 (18.16) |
175.15% | Details | |
| 2/26/2025 | Prothena Corp | PRTA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2025 | Immunovant | IMVT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2025 | Nektar Therapeutics | NKTR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 1/27/2025 | Allakos Inc. | ALLK | Downgrade | Neutral (Overweight) |
1.21 (0.33) |
-72.73% | Details | |
| 1/23/2025 | Bright Minds Biosciences Inc. | DRUG | New Coverage | Overweight (N/A) |
35.49 (66.22) |
86.59% | Details | |
| 1/8/2025 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2025 | Acelyrin Inc | SLRN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/18/2024 | Structure Therapeutics | GPCR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/11/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/19/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2024 | Benitec BioPharma | BNTC | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | Zura Bio Ltd. | ZURA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | Upstream Bio | UPB | New Coverage | Overweight (Overweight) |
24.76 (6.35) |
-74.35% | Details | |
| 11/4/2024 | Nektar Therapeutics | NKTR | New Coverage | Overweight (N/A) |
1.19 (64.84) |
5348.74% | Details | |
| 10/30/2024 | Sage Therapeutics | SAGE | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2024 | Varonis Systems | VRNS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2024 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/21/2024 | aTyr Pharma | ATYR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/21/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/18/2024 | Tenaya Therapeutics Inc | TNYA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/18/2024 | Benitec BioPharma | BNTC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2024 | Lexicon Pharmaceuticals | LXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2024 | AnaptysBio | ANAB | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2024 | Benitec BioPharma | BNTC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/14/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2024 | Allakos Inc. | ALLK | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2024 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2024 | Savara | SVRA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2024 | Lexicon Pharmaceuticals | LXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/7/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2024 | Savara | SVRA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2024 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/2/2024 | AnaptysBio | ANAB | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2024 | Benitec BioPharma | BNTC | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/25/2024 | Acelyrin Inc | SLRN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/24/2024 | Benitec BioPharma | BNTC | Maintain | Overweight (N/A) |
|
Details | ||
| 9/24/2024 | Aligos Therapeutics Inc. | ALGS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2024 | Tectonic Therapeutics Inc. | TECX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/20/2024 | Tectonic Therapeutics Inc. | TECX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/19/2024 | Zura Bio Ltd. | ZURA | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2024 | Pliant Therapeutics | PLRX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2024 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2024 | Korro Bio Inc. | KRRO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2024 | Immunic Inc. | IMUX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2024 | Immunovant | IMVT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2024 | Gossamer Bio Inc. | GOSS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2024 | Aligos Therapeutics Inc. | ALGS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/10/2024 | Structure Therapeutics | GPCR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/4/2024 | Tourmaline Bio | TRML | Maintain | Overweight (N/A) |
|
Details | ||
| 9/4/2024 | Immunic Inc. | IMUX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2024 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2024 | Immunovant | IMVT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2024 | Korro Bio Inc. | KRRO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2024 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2024 | Acelyrin Inc | SLRN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2024 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2024 | Sage Therapeutics | SAGE | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2024 | Varonis Systems | VRNS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2024 | Aligos Therapeutics Inc. | ALGS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/18/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/17/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/16/2024 | Lexicon Pharmaceuticals | LXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2024 | Gossamer Bio Inc. | GOSS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2024 | Arcturus Therapeutics | ARCT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/2/2024 | Arcturus Therapeutics | ARCT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/2/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Edgewise Therapeutics | EWTX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/27/2024 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 6/26/2024 | Allakos Inc. | ALLK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/26/2024 | Tectonic Therapeutics Inc. | TECX | New Coverage | Overweight (N/A) |
15.97 (30.72) |
92.36% | Details | |
| 6/17/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/13/2024 | Benitec BioPharma | BNTC | New Coverage | Overweight (N/A) |
7.50 (13.63) |
81.73% | Details | |
| 6/10/2024 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2024 | Savara | SVRA | Maintain | Overweight (N/A) |
|
Details | ||
| 6/6/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/6/2024 | Aligos Therapeutics Inc. | ALGS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/5/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/31/2024 | Arcturus Therapeutics | ARCT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/31/2024 | Lexicon Pharmaceuticals | LXRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/30/2024 | Immunovant | IMVT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2024 | Prothena Corp | PRTA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2024 | Acelyrin Inc | SLRN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/23/2024 | Pliant Therapeutics | PLRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/23/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/17/2024 | Aligos Therapeutics Inc. | ALGS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2024 | Crinetics | CRNX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2024 | Design Therapeutics Inc | DSGN | Upgrade | Overweight (Neutral) |
3.72 (13.78) |
270.43% | Details | |
| 5/3/2024 | Zura Bio Ltd. | ZURA | New Coverage | Overweight (N/A) |
4.15 (4.26) |
2.65% | Details | |
| 4/16/2024 | Varonis Systems | VRNS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2024 | Verona Pharma | VRNA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/4/2024 | Unicycive Therapeutics | UNCY | New Coverage | Overweight (N/A) |
1.38 (7.89) |
471.74% | Details | |
| 3/7/2024 | Edgewise Therapeutics | EWTX | New Coverage | Overweight (N/A) |
16.97 (42.30) |
149.26% | Details | |
| 3/4/2024 | Savara | SVRA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | AnaptysBio | ANAB | New Coverage | Overweight (N/A) |
22.29 (58.48) |
162.36% | Details | |
| 2/13/2024 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Overweight) |
32.21 (32.48) |
0.84% | Details | |
| 2/5/2024 | Soleno Therapeutics Inc. | SLNO | New Coverage | Overweight (N/A) |
46.92 (52.25) |
11.36% | Details | |
| 1/16/2024 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Overweight (N/A) |
17.11 (32.63) |
90.71% | Details | |
| 12/18/2023 | Structure Therapeutics | GPCR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/14/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Neutral (Overweight) |
7.75 (1.82) |
-76.52% | Details | |
| 11/14/2023 | Design Therapeutics Inc | DSGN | Downgrade | Neutral (Overweight) |
2.05 (13.78) |
572.2% | Details | |
| 11/10/2023 | Korro Bio Inc. | KRRO | New Coverage | Overweight (N/A) |
41.40 (31.42) |
-24.11% | Details | |
| 11/6/2023 | CymaBay Therapeutic | CBAY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2023 | Structure Therapeutics | GPCR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2023 | Tourmaline Bio | TRML | New Coverage | Overweight (N/A) |
9.46 (47.60) |
403.17% | Details | |
| 10/24/2023 | Immunovant | IMVT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2023 | Sagimet Biosciences Inc | SGMT | New Coverage | Overweight (N/A) |
16.09 (6.93) |
-56.93% | Details | |
| 7/27/2023 | Structure Therapeutics | GPCR | New Coverage | Overweight (N/A) |
35.14 (48.16) |
37.05% | Details | |
| 5/30/2023 | Acelyrin Inc | SLRN | New Coverage | Overweight (N/A) |
19.42 (2.27) |
-88.31% | Details | |
| 4/24/2023 | Crinetics | CRNX | New Coverage | Overweight (N/A) |
17.22 (36.18) |
110.1% | Details | |
| 4/18/2023 | Prometheus Biosciences Inc | RXDX | Downgrade | Neutral (Overweight) |
114.01 (199.92) |
75.35% | Details | |
| 3/31/2023 | Immunovant | IMVT | New Coverage | Overweight (N/A) |
15.71 (38.22) |
143.28% | Details | |
| 3/7/2023 | Allakos Inc. | ALLK | New Coverage | Overweight (N/A) |
5.80 (0.33) |
-94.31% | Details | |
| 3/6/2023 | Chinook Therapeutics | KDNY | New Coverage | Overweight (N/A) |
22.81 (40.39) |
77.07% | Details | |
| 2/22/2023 | Cincor Pharma Inc | CINC | Maintain | Overweight (N/A) |
|
Details | ||
| 1/27/2023 | Prothena Corp | PRTA | New Coverage | Overweight (N/A) |
55.25 (9.40) |
-82.99% | Details | |
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/29/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/26/2022 | Verona Pharma | VRNA | New Coverage | Overweight (N/A) |
10.59 (104.77) |
889.33% | Details | |
| 8/22/2022 | Cincor Pharma Inc | CINC | New Coverage | Overweight (N/A) |
35.02 (29.06) |
-17.02% | Details | |
| 8/19/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2022 | Lexicon Pharmaceuticals | LXRX | New Coverage | Overweight (N/A) |
2.78 (2.22) |
-20.14% | Details | |
| 6/10/2022 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2022 | Prometheus Biosciences Inc | RXDX | New Coverage | Overweight (N/A) |
29.00 (199.92) |
589.38% | Details | |
| 6/7/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2022 | Protagonist Therapeutics | PTGX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/29/2022 | Ventyx Biosciences Inc | VTYX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/22/2022 | Sage Therapeutics | SAGE | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2021 | Ventyx Biosciences Inc | VTYX | New Coverage | Overweight (N/A) |
22.97 (13.73) |
-40.23% | Details | |
| 10/12/2021 | Protagonist Therapeutics | PTGX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/5/2021 | Cytokinetics | CYTK | Maintain | Overweight (N/A) |
|
Details | ||
| 9/22/2021 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 9/21/2021 | Gossamer Bio Inc. | GOSS | New Coverage | Overweight (N/A) |
10.52 (0.17) |
-98.38% | Details | |
| 9/8/2021 | Altimmune | ALT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/24/2021 | Tenaya Therapeutics Inc | TNYA | New Coverage | Overweight (N/A) |
22.67 (0.73) |
-96.78% | Details | |
| 8/6/2021 | NGM Biopharmaceuticals | NGM | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2021 | Protagonist Therapeutics | PTGX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2021 | Vaxart Inc. | VXRT | New Coverage | Overweight (N/A) |
7.64 (0.32) |
-95.81% | Details | |
| 6/9/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2021 | Liminal BioSciences, Inc. | LMNL | Downgrade | Neutral (Overweight) |
4.42 (8.50) |
92.31% | Details | |
| 5/21/2021 | Protagonist Therapeutics | PTGX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2021 | Reneo Pharmaceuticals | RPHM | New Coverage | Overweight (N/A) |
14.40 (1.82) |
-87.36% | Details | |
| 4/20/2021 | Design Therapeutics Inc | DSGN | New Coverage | Overweight (N/A) |
23.50 (13.78) |
-41.36% | Details | |
| 4/7/2021 | Sage Therapeutics | SAGE | New Coverage | Overweight (N/A) |
77.89 (6.70) |
-91.4% | Details | |
| 3/16/2021 | Savara | SVRA | New Coverage | Overweight (N/A) |
1.57 (5.83) |
271.34% | Details | |
| 3/9/2021 | CymaBay Therapeutic | CBAY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2021 | Albireo Pharma | ALBO | Maintain | Overweight (N/A) |
|
Details | ||
| 12/21/2020 | Liminal BioSciences, Inc. | LMNL | New Coverage | Overweight (N/A) |
4.09 (8.50) |
107.82% | Details | |
| 12/16/2020 | Protagonist Therapeutics | PTGX | New Coverage | Overweight (N/A) |
20.92 (122.15) |
483.89% | Details | |
| 9/28/2020 | Mirum Pharamceuticals | MIRM | Maintain | Overweight (N/A) |
|
Details | ||
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/4/2020 | Amarin Corporation | AMRN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/26/2020 | Arcturus Therapeutics | ARCT | New Coverage | Overweight (N/A) |
54.24 (7.01) |
-87.08% | Details | |
| 8/26/2020 | Enanta Pharmaceuticals | ENTA | New Coverage | Overweight (N/A) |
49.02 (13.72) |
-72.01% | Details | |
| 8/26/2020 | Immunic Inc. | IMUX | New Coverage | Overweight (N/A) |
15.29 (14.71) |
-3.79% | Details | |
| 8/26/2020 | Lumos Pharma | LUMO | New Coverage | Overweight (N/A) |
14.96 (4.34) |
-70.99% | Details | |
| 8/25/2020 | Amarin Corporation | AMRN | New Coverage | Overweight (N/A) |
6.79 (16.41) |
141.68% | Details | |
| 7/31/2020 | 89bio Inc. | ETNB | New Coverage | Overweight (N/A) |
28.77 (14.84) |
-48.42% | Details | |
| 7/31/2020 | Mirum Pharamceuticals | MIRM | New Coverage | Overweight (N/A) |
20.26 (114.97) |
467.47% | Details | |
| 7/31/2020 | 89bio Inc. | ETNB | New Coverage | Overweight (N/A) |
28.77 (14.84) |
-48.42% | Details | |
| 7/31/2020 | CymaBay Therapeutic | CBAY | New Coverage | Overweight (N/A) |
3.53 (32.48) |
820.11% | Details | |
| 7/31/2020 | Axcella Health Inc. | AXLA | New Coverage | Overweight (N/A) |
4.51 (4.58) |
1.55% | Details | |
| 7/31/2020 | Albireo Pharma | ALBO | New Coverage | Overweight (N/A) |
25.55 (44.15) |
72.8% | Details | |
| 7/31/2020 | NGM Biopharmaceuticals | NGM | New Coverage | Overweight (N/A) |
18.43 (1.54) |
-91.64% | Details | |
| 7/31/2020 | Altimmune | ALT | New Coverage | Overweight (N/A) |
22.52 (2.95) |
-86.9% | Details | |
| 7/31/2020 | Madrigal Pharmaceuticals | MDGL | New Coverage | Overweight (N/A) |
103.30 (509.76) |
393.48% | Details | |
| 7/31/2020 | Intercept Pharmaceuticals | ICPT | New Coverage | Overweight (N/A) |
45.60 (19.00) |
-58.33% | Details |
